I am a
Home I AM A Search Login

Papers of the Week

Papers: 28 Oct 2023 - 3 Nov 2023

2023 Nov 01

Neurol Ther


Real-World Use of Ubrogepant as Acute Treatment for Migraine with an Anti-Calcitonin Gene-Related Peptide Monoclonal Antibody: Results from COURAGE.


Lipton RB, Contreras-De Lama J, Serrano D, Engstrom E, Ayasse ND, Poh W, Cadiou F, Manack Adams A


Although acute and preventive treatments for migraine are commonly given in combination, data on the real-world effectiveness of ubrogepant as an acute treatment when used with an anti-calcitonin gene-related peptide (CGRP) monoclonal antibody (with or without onabotulinumtoxinA) are limited. This analysis sought to evaluate the real-world effectiveness, treatment satisfaction, and optimization of ubrogepant for the acute treatment of migraine when used in combination with an anti-CGRP monoclonal antibody, with or without concomitant onabotulinumtoxinA.